$CATX
Perspective Therapeutics, Inc.

2012 Q4 Form 10-Q Financial Statement

#000114420412062486 Filed on November 14, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q3
Revenue $975.5K $1.056M $1.213M
YoY Change -20.61% -12.95% -8.77%
Cost Of Revenue $1.134M $1.077M $1.147M
YoY Change 10.13% -6.14% 3.34%
Gross Profit -$158.6K -$20.43K $66.34K
YoY Change -179.75% -130.79% -69.84%
Gross Profit Margin -16.26% -1.93% 5.47%
Selling, General & Admin $791.7K $960.9K $967.3K
YoY Change -1.2% -0.67% -0.27%
% of Gross Profit 1458.12%
Research & Development $149.2K $141.5K $251.3K
YoY Change -21.35% -43.71% 128.47%
% of Gross Profit 378.82%
Depreciation & Amortization $180.0K $220.0K $230.0K
YoY Change -21.74% -4.35% 0.0%
% of Gross Profit 346.69%
Operating Expenses $940.8K $1.102M $1.169M
YoY Change -5.06% -5.67% 7.22%
Operating Profit -$1.099M -$1.123M -$1.102M
YoY Change 38.81% 1.86% 26.7%
Interest Expense -$50.00K $130.0K $0.00
YoY Change -131.25%
% of Operating Profit
Other Income/Expense, Net -$54.87K $129.1K $93.00
YoY Change -133.6% 138758.06%
Pretax Income -$1.150M -$990.0K -$1.100M
YoY Change 82.54% -10.0% 26.44%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.154M -$993.7K -$1.102M
YoY Change 83.59% -9.85% 26.69%
Net Earnings / Revenue -118.34% -94.08% -90.84%
Basic Earnings Per Share
Diluted Earnings Per Share -$33.24K -$29.23K -$41.53K
COMMON SHARES
Basic Shares Outstanding 34.60M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.440M $5.030M $1.590M
YoY Change 31.36% 216.35% 55.88%
Cash & Equivalents $4.441M $5.029M $1.595M
Short-Term Investments
Other Short-Term Assets $230.0K $200.0K $210.0K
YoY Change 91.67% -4.76% -32.26%
Inventory $402.9K $410.5K $760.0K
Prepaid Expenses
Receivables $656.2K $845.1K $970.0K
Other Receivables $0.00 $10.00K $20.00K
Total Short-Term Assets $5.736M $6.496M $3.560M
YoY Change 11.17% 82.48% 25.35%
LONG-TERM ASSETS
Property, Plant & Equipment $2.029M $2.210M $3.000M
YoY Change -27.29% -26.32% -19.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $301.1K $301.4K $180.0K
YoY Change 30.9% 67.47% -5.26%
Total Long-Term Assets $2.981M $3.163M $3.460M
YoY Change -9.4% -8.59% -17.62%
TOTAL ASSETS
Total Short-Term Assets $5.736M $6.496M $3.560M
Total Long-Term Assets $2.981M $3.163M $3.460M
Total Assets $8.717M $9.659M $7.020M
YoY Change 3.16% 37.59% -0.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $390.0K $350.0K $550.0K
YoY Change 11.43% -36.36% 27.91%
Accrued Expenses $300.0K $230.0K $370.0K
YoY Change -26.83% -37.84% -22.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $696.8K $578.4K $920.0K
YoY Change -8.31% -37.13% -4.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.000M $930.0K $680.0K
YoY Change -0.99% 36.76% 9.68%
Total Long-Term Liabilities $1.000M $930.0K $680.0K
YoY Change -0.99% 36.76% -8.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $696.8K $578.4K $920.0K
Total Long-Term Liabilities $1.000M $930.0K $680.0K
Total Liabilities $1.694M $1.504M $1.600M
YoY Change -4.28% -5.99% -5.33%
SHAREHOLDERS EQUITY
Retained Earnings -$50.38M -$49.23M
YoY Change
Common Stock $34.61K $34.60K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.390K $8.390K
YoY Change
Treasury Stock Shares $13.20K 13.20K shares
Shareholders Equity $7.022M $8.155M $5.420M
YoY Change
Total Liabilities & Shareholders Equity $8.717M $9.659M $7.020M
YoY Change 3.16% 37.59% -0.28%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income -$1.154M -$993.7K -$1.102M
YoY Change 83.59% -9.85% 26.69%
Depreciation, Depletion And Amortization $180.0K $220.0K $230.0K
YoY Change -21.74% -4.35% 0.0%
Cash From Operating Activities -$570.0K -$938.6K -$542.1K
YoY Change 21.28% 73.15% -15.3%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $6.795K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 -$6.869K -$15.87K
YoY Change -100.0% -56.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.292M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K $3.302M 40.24K
YoY Change -100.44% 8103.74% -502.44%
NET CHANGE
Cash From Operating Activities -570.0K -$938.6K -542.1K
Cash From Investing Activities 0.000 -$6.869K -15.87K
Cash From Financing Activities -10.00K $3.302M 40.24K
Net Change In Cash -580.0K $2.356M -517.7K
YoY Change -132.4% -555.08% -20.35%
FREE CASH FLOW
Cash From Operating Activities -$570.0K -$938.6K -$542.1K
Capital Expenditures $0.00 $6.795K
Free Cash Flow -$570.0K -$938.6K -$548.9K
YoY Change 23.91% 71.01% -14.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34597717 shares
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2112254
CY2012Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
144116
CY2012Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
469758
CY2012Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
52000
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
301691
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
5818192
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
193000000 shares
CY2012Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
119881
CY2012Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30950108 shares
CY2012Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1959799 shares
CY2012Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
114124
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2102964 shares
CY2012Q2 us-gaap Liabilities
Liabilities
1687290
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48234738
CY2012Q2 us-gaap Assets
Assets
7505482
CY2012Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
88006
CY2012Q2 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
9925
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
865056
CY2012Q2 us-gaap Inventory Net
InventoryNet
444345
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7505482
CY2012Q2 us-gaap Treasury Stock Value
TreasuryStockValue
8390
CY2012Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181027
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
193000000 shares
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2672711
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30950108 shares
CY2012Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
724298
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2283968 shares
CY2012Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
389105
CY2012Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
261835
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
648992
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57604
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2381306 shares
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
30950
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q2 us-gaap Assets Current
AssetsCurrent
4136153
CY2012Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
68386
CY2012Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
314000
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2416853
CY2012Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54030311
CY2012Q2 isr Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
1.3800
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1594545
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
200948
CY2012Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
469758
CY2012Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
64000
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
301439
CY2012Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
138388
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2050764 shares
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
8155001
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
73457
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.92
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
253608
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34597717 shares
CY2012Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1957133 shares
CY2012Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
218408
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2050764 shares
CY2012Q3 us-gaap Liabilities
Liabilities
1504102
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49228406
CY2012Q3 us-gaap Assets
Assets
9659103
CY2012Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
93322
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.81
CY2012Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
11140
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
845098
CY2012Q3 us-gaap Inventory Net
InventoryNet
410464
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2232855 shares
CY2012Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
347606
CY2012Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
142640
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
578385
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
109076
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2325772 shares
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
34598
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q3 us-gaap Assets Current
AssetsCurrent
6496377
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9659103
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
251308
CY2012Q3 us-gaap Treasury Stock Value
TreasuryStockValue
8390
CY2012Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181069
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
230622
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5028727
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34597717 shares
CY2012Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
740717
CY2012Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
49416
CY2012Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
185000
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2210460
CY2012Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57357140
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.86
CY2012Q3 isr Common Stock Warrants Fair Value
CommonStockWarrantsFairValue
484000
CY2012Q3 isr Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
1.3800
CY2012Q3 isr Warrant Liabilities Fair Value Disclosure
WarrantLiabilitiesFairValueDisclosure
185000
CY2012Q3 isr Class Of Warrant Or Right Issued In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightIssuedInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0.6715
CY2012Q3 isr Number Of Warrants Outstanding
NumberOfWarrantsOutstanding
713601 shares
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1102317
CY2011Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
15011
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1213417
CY2011Q3 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
8351
CY2011Q3 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
50000
CY2011Q3 us-gaap Share Based Compensation
ShareBasedCompensation
33189
CY2011Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
176545
CY2011Q3 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
71
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2011Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
216806
CY2011Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-542086
CY2011Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15867
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
187
CY2011Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6795
CY2011Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-517709
CY2011Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-52346
CY2012Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2012Q3 dei Document Type
DocumentType
10-Q
CY2011Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
652927
CY2011Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
70703
CY2011Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
225759
CY2011Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
40244
CY2011Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
314418
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
251314
CY2011Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40244
CY2011Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
94
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
1168659
CY2011Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3378
CY2011Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12057
CY2011Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
6714
CY2011Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1147075
CY2011Q3 us-gaap Gross Profit
GrossProfit
66342
CY2011Q3 us-gaap Interest Paid
InterestPaid
94
CY2011Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9001
CY2011Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26487140 shares
CY2011Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6161956 shares
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-1102224
CY2011Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
93
CY2011Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-406537
CY2011Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1104882
CY2011Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
8307
CY2011Q3 isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
-46165
CY2012Q3 dei Trading Symbol
TradingSymbol
ISR
CY2012Q3 dei Entity Registrant Name
EntityRegistrantName
ISORAY, INC.
CY2012Q3 dei Amendment Flag
AmendmentFlag
false
CY2012Q3 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q3 dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
CY2012Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000728387
CY2012Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11400
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1122806
CY2012Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
16419
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1056232
CY2012Q3 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
5316
CY2012Q3 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercised In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisedInPeriod
18633 shares
CY2012Q3 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Exercisable Forfeited In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExercisableForfeitedInPeriod
34200 shares
CY2012Q3 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Exercisable Exercised In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExercisableExercisedInPeriod
18000 shares
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y3M29D
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
28963
CY2012Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-41499
CY2012Q3 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
42
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2012Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18000 shares
CY2012Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
206393
CY2012Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7746
CY2012Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-938629
CY2012Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6869
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
144
CY2012Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
129000
CY2012Q3 isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
-51472
CY2012Q3 isr Issuance Of Common Stock In Connection With Warrant Exercises Net Of Issuance Costs Shares
IssuanceOfCommonStockInConnectionWithWarrantExercisesNetOfIssuanceCostsShares
2666 shares
CY2012Q3 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Forfeited In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestForfeitedInPeriod
32480 shares
CY2012Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2356016
CY2012Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-46424
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
644853
CY2012Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
56832
CY2012Q3 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="FONT: 10pt Times New Roman, Times, Serif"> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.5in"><b>2.</b></td> <td style="TEXT-ALIGN: justify"><b>New Accounting Pronouncements</b></td> </tr> </table> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>&#xA0;</b></p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the &#x201C;FASB&#x201D;) or other standards setting bodies that are adopted by us as of the specified effective dates. Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.</p> </div>
CY2012Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
3291977
CY2012Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P10M10D
CY2012Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31514
CY2012Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1791
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
316056
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
141472
CY2012Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3301514
CY2012Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
6
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
37534 shares
CY2012Q3 isr Effective Income Tax Rate
EffectiveIncomeTaxRate
0.00 pure
CY2012Q3 isr Gains And Losses Due To Changes In Fair Value
GainsAndLossesDueToChangesInFairValue
129000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
1102381
CY2012Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-33881
CY2012Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7079
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M17D
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1076657
CY2012Q3 us-gaap Gross Profit
GrossProfit
-20425
CY2012Q3 us-gaap Interest Paid
InterestPaid
6
CY2012Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
6827
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33866563 shares
CY2012Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4341970 shares
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-993668
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
129138
CY2012Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1215
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-996326
CY2012Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
12000

Files In Submission

Name View Source Status
0001144204-12-062486-index-headers.html Edgar Link pending
0001144204-12-062486-index.html Edgar Link pending
0001144204-12-062486.txt Edgar Link pending
0001144204-12-062486-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
isr-20120930.xml Edgar Link completed
isr-20120930.xsd Edgar Link pending
isr-20120930_cal.xml Edgar Link unprocessable
isr-20120930_def.xml Edgar Link unprocessable
isr-20120930_lab.xml Edgar Link unprocessable
isr-20120930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v327045_10q.htm Edgar Link pending
v327045_ex31-1.htm Edgar Link pending
v327045_ex31-2.htm Edgar Link pending
v327045_ex32.htm Edgar Link pending